Funding
Cancer
CANCER
This trial was funded by Climb Plan of Hunan Cancer Hospital (No. ZX2021005), Chinese Anti-Cancer Association HER2 target Chinese Research Fund (No. CORP-239-S5), Changsha Science and Technology Project (No. kq2004137) and Hunan Provincial Natural Science Foundation of China (No. 2023JJ60464).